1. Home
  2. Stock quotes
  3. Stock Kezar Life Sciences
Kezar Life Sciences logo

Kezar Life Sciences KZR

$ 7.5 0.13%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Country

 usaUSA

IPO year

 2018

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

CEO

 Mr. John Fowler

Employees in the company

 40

Shares

 72.6 M

Market Cap[1]

 $ 544 M

EBITDA (LTM)

 $ -93.4 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		$ 0.27 -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
 		$ 10.41 -5.36 % $ 43.9 M Nasdaq Global Market usaUSA
Aytu BioScience Aytu BioScience
AYTU
 		$ 1.5 1.35 % $ 8.31 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		$ 1.47 -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		$ 4.93 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
Black Diamond Therapeutics Black Diamond Therapeutics
BDTX
 		$ 2.35 -3.29 % $ 103 M Nasdaq Global Select Market,SPB usaUSA
Advaxis Advaxis
ADXS
 		$ 0.31 -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		$ 3.93 -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		$ 6.2 - $ 154 M Nasdaq Capital Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 6.42 - $ 404 M NYSE canadaCanada
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		$ 10.5 - $ 231 M Nasdaq Global Market usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		$ 9.5 - $ 1.7 B Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		$ 2.58 -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Zosano Pharma Corporation Zosano Pharma Corporation
ZSAN
 		$ 0.56 7.23 % $ 2.72 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		$ 0.5 - $ 7.46 M Nasdaq Global Market israelIsrael
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		$ 179.68 - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		$ 44.15 -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		$ 0.32 - $ 23.9 M Nasdaq Global Select Market usaUSA
BELLUS Health BELLUS Health
BLU
 		$ 14.74 - $ 2.47 B Nasdaq Global Select Market canadaCanada
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		$ 18.44 - $ 1.94 B Nasdaq Capital Market canadaCanada

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.